IRAK1: oncotarget in MDS and AML
IRAK1: oncotarget in MDS and AML |
|
https://doi.org/10.18632/oncotarget.1880
Levi J. Beverly,
and Daniel T. Starczynowski
|
| 1699-1700 |
Pathways and therapeutic targets in melanoma
Pathways and therapeutic targets in melanoma |
|
https://doi.org/10.18632/oncotarget.1892
Emma Shtivelman,
Michael A. Davies,
Patrick Hwu,
James Yang,
Michal Lotem,
Moshe Oren,
Keith T. Flaherty,
and David E. Fisher
|
| 1701-1752 |
Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs |
|
https://doi.org/10.18632/oncotarget.1524
Joshua E. E. Allen,
Bikramajit Singh Saroya,
Miriam Kunkel,
David . T. Dicker,
Avisnata Das,
Kristi L. Peters,
Jamal Joudeh,
Junjia Zhu,
and Wafik S. El-Deiry
|
| 1753-1760 |
Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo
Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivo |
|
https://doi.org/10.18632/oncotarget.1761
John T. Heap,
Jan Theys,
Muhammad Ehsaan,
Aleksandra M Kubiak,
Ludwig Dubois,
Kim Paesmans,
Lieve Van Mellaert,
Richard Knox,
Sarah A. Kuehne,
Phillipe Lambin,
and Nigel P. Minton
|
| 1761-1769 |
Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response
Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response |
|
https://doi.org/10.18632/oncotarget.1678
Marcella Salzano,
Marta Vázquez-Cedeira,
Marta Sanz-García,
Alberto Valbuena,
Sandra Blanco,
Isabel F. Fernández,
and Pedro A. Lazo
|
| 1770-1778 |
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.1736
Enrica Borsi,
Giulia Perrone,
Carolina Terragna,
Marina Martello,
Angela F Dico,
Giancarlo Solaini,
Alessandra Baracca,
Gianluca Sgarbi,
Gianandrea Pasquinelli,
Sabrina Valente,
Elena Zamagni,
Paola Tacchetti,
Giovanni Martinelli,
and Michele Cavo
|
| 1779-1792 |
The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1
The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1 |
|
https://doi.org/10.18632/oncotarget.1785
Andrew E. Tee,
Dora Ling,
Charlotte Nelson,
Bernard Atmadibrata,
Marcel E. Dinger,
Ning Xu,
Tamio Mizukami,
Pei Y. Liu,
Bing Liu,
Belamy Cheung,
Eddy Pasquier,
Michelle Haber,
Murray D. Norris,
Takayoshi Suzuki,
Glenn M. Marshall,
and Tao Liu
|
| 1793-1804 |
Utilization of Rad51C promoter for transcriptional targeting of cancer cells
Utilization of Rad51C promoter for transcriptional targeting of cancer cells |
|
https://doi.org/10.18632/oncotarget.1792
Yan Cao,
Yan Xu,
Lei Zhang,
Zhen Li,
Ying Jiang,
Xiao Tian,
Andrei Seluanov,
Vera Gorbunova,
and Zhiyong Mao
|
| 1805-1811 |
Inhibition of HER2-Integrin signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression
Inhibition of HER2-Integrin signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression |
|
https://doi.org/10.18632/oncotarget.1743
Parul Gupta,
and Sanjay K. Srivastava
|
| 1812-1828 |
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas |
|
https://doi.org/10.18632/oncotarget.1829
Kun Wang,
Tiantian Liu,
Li Liu,
Jikai Liu,
Cheng Liu,
Chang Wang,
Nan Ge,
Hongbo Ren,
Keqiang Yan,
Sanyuan Hu,
Magnus Björkholm,
Yidong Fan,
and Dawei Xu
|
| 1829-1836 |
MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit
MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit |
|
https://doi.org/10.18632/oncotarget.1828
Denis L. Fontes Jardim,
Debora de Melo Gagliato,
Gerald S. Falchook,
Filip Janku,
Ralph Zinner,
Jennifer J. Wheler,
Vivek Subbiah,
Sarina A. Piha-Paul,
Siqing Fu,
Mariela Blum Murphy,
Jaffer Ajani,
Chad Tang,
Kenneth Hess,
Stanley R. Hamilton,
Sinchita Roy-Chowdhuri,
Razelle Kurzrock,
Funda Meric-Bernstam,
and David S. Hong
|
| 1837-1845 |
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus |
|
https://doi.org/10.18632/oncotarget.1834
Sarina A. Piha-Paul,
Jennifer J. Wheler,
Siqing Fu,
Charles Levenback,
Karen Lu,
Gerald S. Falchook,
Aung Naing,
David S. Hong,
Apostolia M. Tsimberidou,
and Razelle Kurzrock
|
| 1846-1855 |
ΔNp63 isoform-mediated β-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma
ΔNp63 isoform-mediated β-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.1819
Meggy Suarez-Carmona,
Pascale Hubert,
Arnaud Gonzalez,
Anaelle Duray,
Patrick Roncarati,
Charlotte Erpicum,
Jacques Boniver,
Vincent Castronovo,
Agnès Noel,
Sven Saussez,
Olivier Peulen,
Philippe Delvenne,
and Michael Herfs
|
| 1856-1868 |
The immunocytokine NHS-IL12 as a potential cancer therapeutic
The immunocytokine NHS-IL12 as a potential cancer therapeutic |
|
https://doi.org/10.18632/oncotarget.1853
Jonathan Fallon,
Robert Tighe,
Giorgio Kradjian,
Wilson Guzman,
Anna Bernhardt,
Berend Neuteboom,
Yan Lan,
Helen Sabzevari,
Jeffrey Schlom,
and John W. Greiner
|
| 1869-1884 |
Biglycan enhances gastric cancer invasion by activating FAK signaling pathway
Biglycan enhances gastric cancer invasion by activating FAK signaling pathway |
|
https://doi.org/10.18632/oncotarget.1871
Lei Hu,
Yan-tao Duan,
Jian-fang Li,
Li-ping Su,
Min Yan,
Zheng-gang Zhu,
Bing-ya Liu,
and Qiu-meng Yang
|
| 1885-1896 |
γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model |
|
https://doi.org/10.18632/oncotarget.1876
Kodappully Sivaraman Siveen,
Kwang Seok Ahn,
Tina H. Ong,
Muthu K. Shanmugam,
Feng Li,
Wei Ney Yap,
Alan Prem Kumar,
Chee Wai Fong,
Vinay Tergaonkar,
Kam M. Hui,
and Gautam Sethi
|
| 1897-1911 |
Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome?
Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome? |
|
https://doi.org/10.18632/oncotarget.1877
Fazila Asmar,
Christoffer Hother,
Gorjan Kulosman,
Marianne Bach Treppendahl,
Helene Myrtue Nielsen,
Ulrik Ralfkiaer,
Anja Pedersen,
Michael Boe Møller,
Elisabeth Ralfkiaer,
Peter de Nully Brown,
and Kirsten Grønbæk
|
| 1912-1925 |
PDGFRα up-regulation mediated by Sonic Hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation
PDGFRα up-regulation mediated by Sonic Hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation |
|
https://doi.org/10.18632/oncotarget.1878
Francesco Sabbatino,
Yangyang Wang,
Xinhui Wang,
Keith T. Flaherty,
Ling Yu,
David Pepin,
Giosue’ Scognamiglio,
Stefano Pepe,
John M. Kirkwood,
Zachary A. Cooper,
Dennie T. Frederick,
Jennifer A. Wargo,
Soldano Ferrone,
and Cristina R. Ferrone
|
| 1926-1941 |
Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics
Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics |
|
https://doi.org/10.18632/oncotarget.1879
Manuel Puig-Costa,
Antonio Codina-Cazador,
Elisabet Cortés-Pastoret,
Cristina Oliveras-Ferraros,
Sílvia Cufí,
Sílvia Flaquer,
Francesca Llopis-Puigmarti,
Eulalia Pujol-Amado,
Bruna Corominas-Faja,
Elisabet Cuyàs,
Rosa Ortiz,
Eugeni Lopez-Bonet,
Bernardo Queralt,
Raquel Guardeño,
Begoña Martin-Castillo,
Josep Roig,
Jorge Joven,
and Javier A. Menendez
|
| 1942-1954 |
A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells
A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells |
|
https://doi.org/10.18632/oncotarget.1885
Xiao Chen,
Jingqin Fang,
Shunan Wang,
Heng Liu,
Xuesong Du,
Jinhua Chen,
Xue Li,
Yizeng Yang,
Bo Zhang,
and Weiguo Zhang
|
| 1955-1968 |
CHIP is a novel tumor suppressor in pancreatic cancer and inhibits tumor growth through targeting EGFR
CHIP is a novel tumor suppressor in pancreatic cancer and inhibits tumor growth through targeting EGFR |
|
https://doi.org/10.18632/oncotarget.1890
Tianxiao Wang,
Jingxuan Yang,
Jianwei Xu,
Jian Li,
Zhe Cao,
Li Zhou,
Lei You,
Hong Shu,
Zhaohui Lu,
Huihua Li,
Min Li,
Taiping Zhang,
and Yupei Zhao
|
| 1969-1986 |
Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach
Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach |
|
https://doi.org/10.18632/oncotarget.1898
Chandra K. Singh,
Jasmine George,
Minakshi Nihal,
Grzegorz Sabat,
Raj Kumar,
and Nihal Ahmad
|
| 1987-1999 |
